Why is Shree Ganesh Bio falling/rising?

As of 25-Jul, Shree Ganesh Biotech India Ltd is experiencing a decline in its stock price, currently at Rs. 0.80, reflecting a decrease of Rs. 0.01 or 1.23%. The stock has hit a new 52-week low today and has underperformed its sector by 1.47%. It has been on a downward trend for the last two days, with a total decline of 2.44% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company is facing significant challenges, including operating losses and a weak ability to service its debt, indicated by a poor EBIT to Interest ratio of 0.98. The return on equity is also low at 2.60%, suggesting low profitability, which has contributed to a substantial decline in stock performance over the past year, with a return of -33.88%.
In the broader market context, Shree Ganesh Biotech's short-term performance has been notably worse than the benchmark, with a one-week return of -1.23% compared to the Sensex's -0.36%. The company's liquidity appears to be declining, as evidenced by a 32.68% drop in delivery volume against the 5-day average. This lack of investor participation, combined with the company's weak long-term fundamentals and negative EBITDA, paints a concerning picture for potential investors. Overall, these factors contribute to a perception of the stock as a strong sell, reflecting the broader challenges the company faces in the current market environment.